One2Treat is a forward-thinking partner for biopharmaceutical companies, dedicated to delivering transformative insights in clinical trial design, analysis, and market access evaluations to support holistic treatment decisions. One2Treat was founded in July 2023 after four years of advanced Research and Software Development incubation within IDDI Group.

Driven by a commitment to patient-centricity, One2Treat leverages modern statistical methodologies and advanced software solutions, ushering in a new era of personalized healthcare.

Biotechnology

Clinical Trials

Life Sciences

Pharmaceutical

One2Treat

One2Treat's headquarters in Louvain-la-Neuve, Belgium

Description

People (4)

Sébastien Coppe, PhD

Jean-Christophe Chiêm

Samuel Salvaggio

Marc Buyse

Jobs